Atara Biotherapeutics

Atara Biotherapeutics (NASDAQ: ATRA) is a leading off-the-shelf allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune diseases, and viral diseases. Founded in 2012, the company is named after Atara Ciechanover, who passed away after battling cancer.